Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering breakthrough treatment for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
2.21
-0.05 (-2.21%)
Range 2.175 - 2.27
Open 2.25
Prev Close 2.26
52 Week 1.45 - 3.28
Volume 253281
Market Cap 1.134B
*Delayed 6/19/2013 3:03 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000